Search Results - "Gothe, H"

Refine Results
  1. 1

    Economic burden of stroke: a systematic review on post-stroke care by Rajsic, S., Gothe, H., Borba, H. H., Sroczynski, G., Vujicic, J., Toell, T., Siebert, Uwe

    Published in The European journal of health economics (01-02-2019)
    “…Objectives Stroke is a leading cause for disability and morbidity associated with increased economic burden due to treatment and post-stroke care (PSC). The…”
    Get full text
    Journal Article
  2. 2

    Epidemiology, treatment and costs of osteoporosis in Germany : the BoneEVA study by HÄUSSLER, B, GOTHE, H, GÖL, D, GLAESKE, G, PIENTKA, L, FELSENBERG, D

    Published in Osteoporosis international (01-01-2007)
    “…In Germany, accurate data on the prevalence and treatment of osteoporosis, as well as the cost of this illness, are not available. The aim of this study is to…”
    Get full text
    Journal Article
  3. 3

    Is there an unmet medical need for palliative care services in Germany? Incidence, prevalence, and 1-year all-cause mortality of palliative care sensitive conditions: real-world evidence based on German claims data by Gothe, H., Brinkmann, C., Schmedt, N., Walker, J., Ohlmeier, C.

    Published in Journal of public health (01-03-2022)
    “…Aim To characterize palliative care patients, to estimate the incidence, prevalence, and 1-year all-cause mortality in patients in Germany who received…”
    Get full text
    Journal Article
  4. 4

    Epidemiology and routine care treatment of patients with hip or knee osteoarthritis and chronic lower back pain: real-world evidence from Germany by Hradetzky, E., Ohlmeier, C., Brinkmann, C., Schild, M., Galetzka, W., Schmedt, N., John, T., Kaleth, D., Gothe, H.

    Published in Journal of public health (01-12-2022)
    “…Aim Musculoskeletal disorders are a major public health problem in most developed countries. As a main cause of chronic pain, they have resulted in an…”
    Get full text
    Journal Article
  5. 5

    Pharmacoepidemiology. Analysis of drug prescription data by Gothe, H

    “…Due to an increase in pharmaceutical expenditure and growing demands on the observation and analysis of the pharmaceutical use in the overall population,…”
    Get full text
    Journal Article
  6. 6

    The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review by Gothe, H., Schall, I., Saverno, K., Mitrovic, M., Luzak, A., Brixner, D., Siebert, U.

    Published in Applied health economics and health policy (01-08-2015)
    “…Background Generic drugs are considered therapeutically equivalent to their original counterparts and lower in acquisition costs. However, the overall impact…”
    Get full text
    Journal Article
  7. 7

    Continuously tunable laser emission from a wedge-shaped organic microcavity by Schütte, B., Gothe, H., Hintschich, S. I., Sudzius, M., Fröb, H., Lyssenko, V. G., Leo, K.

    Published in Applied physics letters (21-04-2008)
    “…We present an organic microcavity laser with wide tunability in the range of 595–650nm, having a threshold as low as 2nJ/pulse. The active medium consists of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Pathways to care and psychological problems of general practice patients in a gate keeper and an open access health care system: A comparison of Germany and the Netherlands by LINDEN, M, GOTHE, H, ORMEL, J

    “…The comparison of different health care systems is one way to give empirical evidence to health care reform and policy. The differences between health care…”
    Get full text
    Journal Article
  11. 11

    Consideration of international generic distribution policies on patient outcomes in the United States and Germany by Saverno, K, Gothe, H, Schuessel, K, Biskupiak, J, Schulz, M, Siebert, U, Brixner, D

    Published in Pharmazie (01-03-2014)
    “…Generic substitution of narrow therapeutic index drugs can have unintended consequences. Generic switching is often driven by cost incentives, regulations and…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Excess health care costs of obesity in adults with diabetes mellitus: a claims data analysis by von Lengerke, T, Hagenmeyer, E-G, Gothe, H, Schiffhorst, G, Happich, M, Häussler, B

    “…Body weight management is a key factor in diabetes mellitus. However, both behavioral and pharmacological innovations to manage obesity may imply additional…”
    Get more information
    Journal Article
  14. 14

    Pain-specific diagnosis patterns in claims data - Identification by means of classification and regression trees (CART) by Schiffhorst, G, Freytag, A, Höer, A, Häussler, B, Gothe, H

    “…The identification of beneficiaries with persistent, recurrent or chronic pain in claims data by means of individual diagnoses or analgesic prescription is not…”
    Get more information
    Journal Article
  15. 15

    Identification and grouping of pain patients according to claims data by Freytag, A, Schiffhorst, G, Thoma, R, Strick, K, Gries, C, Becker, A, Treede, R-D, Müller-Schwefe, G, Casser, H-R, Luley, C, Höer, A, Ujeyl, M, Gothe, H, Kugler, J, Glaeske, G, Häussler, B

    Published in Schmerz (Berlin, Germany) (01-02-2010)
    “…The ICD classification does not provide the opportunity to adequately identify pain patients. Therefore we developed an alternative method for the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Specialty training and the personal use of benzodiazepines by physicians affect their proneness to prescribe tranquilizers by Linden, M, Gothe, H

    Published in Pharmacopsychiatry (01-03-1998)
    “…The decision on how to treat a patient does not depend on clinical matters or illness characteristics alone, but also on patient, physician and setting…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20